These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9424727)

  • 1. [Regulation of the cell cycle and the development of cancer: therapeutic prospects].
    Peralta-Zaragoza O; Bahena-Román M; Díaz-Benítez CE; Madrid-Marina V
    Salud Publica Mex; 1997; 39(5):451-62. PubMed ID: 9424727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.
    Newton HB
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):177-91. PubMed ID: 15757449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle control and cancer.
    Hartwell LH; Kastan MB
    Science; 1994 Dec; 266(5192):1821-8. PubMed ID: 7997877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.
    D'Assoro AB; Busby R; Suino K; Delva E; Almodovar-Mercado GJ; Johnson H; Folk C; Farrugia DJ; Vasile V; Stivala F; Salisbury JL
    Oncogene; 2004 May; 23(23):4068-75. PubMed ID: 15064746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell cycle and cancer--from the tumor cell line to the patient].
    Fey MF
    Praxis (Bern 1994); 2000 Mar; 89(11):435-7. PubMed ID: 10758729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
    Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
    Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.
    Rodríguez-González A; Ramírez de Molina A; Benítez-Rajal J; Lacal JC
    Prog Cell Cycle Res; 2003; 5():191-201. PubMed ID: 14593713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of apoptosis signaling pathways and cell cycle regulation.
    Eastman A; Rigas JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):7-16; discussion 41-2. PubMed ID: 10585003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SV40 and cell cycle perturbations in malignant mesothelioma.
    Testa JR; Giordano A
    Semin Cancer Biol; 2001 Feb; 11(1):31-8. PubMed ID: 11243897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell cycle-targeted therapy].
    Ree AH
    Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2479-82. PubMed ID: 15477884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
    Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
    Wallerand H; Reiter RR; Ravaud A
    Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.